Abbott Laboratories (ABT)
Abbott (ABT) Rises Yet Lags Behind Market: Some Facts Worth Knowing
In the closing of the recent trading day, Abbott (ABT) stood at $103.56, denoting a +1.7% move from the preceding trading day.
A Dividend King on Sale: Is Abbott Labs a Healthcare Bargain?
In the world of investing, stability is a prized commodity. Few companies embody that stability better than Abbott Laboratories NYSE: ABT, a diversified healthcare powerhouse and a member of the elite dividend kings.
Abbott: A Brighter Investment Case Heading Into Q1 Earnings (Rating Upgrade)
During a year when other healthcare stocks from the S&P500 have remained roughly flat, Abbott Laboratories (ABT) has struggled and lost ground by 22%. ABT which will announce Q1 earnings on the 16th of April is facing low revenue expectations for the quarter, but double-digit growth is expected in the following quarters. I highlight how ABT's financial profile and FCF base is solid enough to support continued annual dividend hikes where the yield is now at-year highs.
Reasons to Retain Abbott Stock in Your Portfolio Now
ABT's Nutrition rebound and FreeStyle Libre growth fuel momentum, but currency swings and macro pressures could cloud near-term performance.
Here is What to Know Beyond Why Abbott Laboratories (ABT) is a Trending Stock
Zacks.com users have recently been watching Abbott (ABT) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
2 Defensive Healthcare Stocks to Buy Right Now
Defensive stocks should help your portfolio weather the toughest market times. The revenue growth of these companies doesn't depend on the economic backdrop.
Is Trending Stock Abbott Laboratories (ABT) a Buy Now?
Recently, Zacks.com users have been paying close attention to Abbott (ABT). This makes it worthwhile to examine what the stock has in store.
DGI For The DIY: 2025 Dividend Portfolio Review
2025 saw heightened volatility amid political change, global tariffs, inflation fears, and ongoing geopolitical conflicts. Despite macro headwinds, equity markets advanced, propelled by AI sector enthusiasm and anticipated interest rate cuts. Market resilience highlights investor confidence in technology-driven growth and accommodative monetary policy.
Abbott Laboratories $ABT Stake Increased by Banco Bilbao Vizcaya Argentaria S.A.
Banco Bilbao Vizcaya Argentaria S.A. raised its stake in shares of Abbott Laboratories (NYSE: ABT) by 9.9% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 157,256 shares of the healthcare product maker's stock after acquiring an additional 14,112 shares during the
Cinctive Capital Management LP Raises Position in Abbott Laboratories $ABT
Cinctive Capital Management LP lifted its stake in Abbott Laboratories (NYSE: ABT) by 87.3% in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 40,254 shares of the healthcare product maker's stock after purchasing an additional 18,763 shares during the period. Cinctive
Glenmede Investment Management LP Has $159.51 Million Stock Holdings in Abbott Laboratories $ABT
Glenmede Investment Management LP lowered its position in shares of Abbott Laboratories (NYSE: ABT) by 4.9% in the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 1,190,887 shares of the healthcare product maker's stock after selling 61,675 shares during the quarter. Abbott Laboratories accounts
Absolute Software Co. (ABT.TO) (TSE:ABT) Stock Price Crosses Above Two Hundred Day Moving Average – Here’s Why
Absolute Software Co. (ABT.TO) (TSE: ABT - Get Free Report)'s stock price crossed above its 200-day moving average during trading on Thursday. The stock has a 200-day moving average of C$0.00 and traded as high as C$19.29. Absolute Software Co. (ABT.TO) shares last traded at C$19.29, with a volume of 554 shares. Absolute Software Co.
